✦ LIBER ✦

PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Trial-Based and Real-Life Cost-Consequence Analysis

✍ Scribed by M. Benucci; W. Stam; I. Gilloteau; D. Crocchiolo; K. Sennfält; A. Leclerc; N. Bengtsson; A. Maetzel; C. Lucioni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS29 CANADIAN COST-EFFECTIVENESS ANALYS

✍ D Zou; O Desjardins; N Tsao; R Goeree 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Cost-Effectiveness Of Abatacept For The

✍ Elgart, J.F.; Gonzalez, L.; Aiello, E.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PMS9 COST-EFFECTIVENESS OF ABATACEPT IN

✍ M Maier-Moldovan; Y Yuan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS14 A COST-EFFECTIVENESS ANALYSIS OF B

✍ PK Gandhi; JJ Spooner; P Viraparia; TL Kauf 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PMS39 COST-UTILITY OF ABATACEPT IN RHEUM

✍ LG Mantovani; S De Portu; M Intorcia; I Olivieri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Safety and efficacy of combination thera

✍ Hara, Masako; Ishiguro, Naoki; Katayama, Kou; Kondo, Masakazu; Sumida, Takayuki; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 337 KB